Daan Gene Co.,Ltd.

The company was listed on the Shenzhen Stock Exchange in 2004. After years of independent innovation and steady management accumulation, Daan Gene has been selected as a national intellectual property demonstration enterprise several times, and its self-developed products have won titles such as “National Key New Product” and “Key New Product of Guangdong Province”. The company is a biomedical high-tech enterprise which is dominated by molecular diagnostic technology and integrates R&D, production and sales of clinical test reagents, instruments and supporting consumables. Main products: fluorescence quantitative PCR series products (clinical), fluorescence quantitative PCR series products (public health), sequencing series products, chemiluminescence series products, time-resolved series products, colloidal gold series products, enzymatic immunization series products, biochemical series products, mass spectrometry series products, POCT series products, instrument products, sample collection series products, nucleic acid extraction series products, testing service products, scientific research service products. Corporate honors: The first batch of national-level intellectual property advantage enterprises in 2013; 2008 to 2009 A tax certificate; 2010 Guangzhou's first outstanding independent innovation enterprise; 2010 Guangzhou Engineering Technology Research and Development Center; 2010 Guangdong Top Ten Innovative Enterprises Nomination Award; 2010 Guangdong Famous Trademark Certificate, etc.